Cargando…
Extemporaneous formulations for pediatric, geriatric, and special needs patients /
Since its first publication, Extemporaneous Formulations, by Rita Jew, Winson Soo-Hoo, Sarah Erush, and Elham Amiri, has been the go-to guide for treating patients who require any of the 80% of medications not commercially available in appropriate forms or dosages for pediatric, geriatric, or specia...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Bethesda, Maryland :
American Society of Health-System Pharmacists,
[2016]
|
| Edición: | Third edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn945613553 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr mn||||||||| | ||
| 008 | 160402t20162016mdu ob 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e rda |e pn |c EBLCP |d YDXCP |d OCLCO |d OCLCF |d OSU |d USU |d MERUC |d OCLCQ |d AU@ |d DKU |d OCLCO |d OCLCQ |d WYU |d OCLCA |d TETON |d OCLCO |d YDX |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d OCLCQ |d AAA |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
| 019 | |a 1182568235 | ||
| 020 | |a 9781585285259 |q (electronic bk.) | ||
| 020 | |a 1585285250 |q (electronic bk.) | ||
| 020 | |z 9781585285242 | ||
| 020 | |z 1585285242 | ||
| 035 | |a (OCoLC)945613553 |z (OCoLC)1182568235 | ||
| 050 | 4 | |a RM301.25 | |
| 060 | 4 | |a 2016 E-286 | |
| 060 | 4 | |a QV 25 | |
| 082 | 0 | 4 | |a 615/.4 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Jew, Rita K., |e author. | |
| 245 | 1 | 0 | |a Extemporaneous formulations for pediatric, geriatric, and special needs patients / |c Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, Elham Amiri. |
| 250 | |a Third edition. | ||
| 264 | 1 | |a Bethesda, Maryland : |b American Society of Health-System Pharmacists, |c [2016] | |
| 264 | 4 | |c ©2016 | |
| 300 | |a 1 online resource (xiii, 232 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Preceded by Extemporaneous formulations for pediatric, geriatric, and special needs patients / Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush. 2nd ed. ©2010. | ||
| 520 | |a Since its first publication, Extemporaneous Formulations, by Rita Jew, Winson Soo-Hoo, Sarah Erush, and Elham Amiri, has been the go-to guide for treating patients who require any of the 80% of medications not commercially available in appropriate forms or dosages for pediatric, geriatric, or special needs. Now even more comprehensive, the third edition provides the same evidence-based formulation in easy-to-follow ""recipes"" for 197 nonsterile formulations, 39 of which are new, and two of which have been updated. Each ""recipe"" includes: Ingredients Preparation details and instructions Stor | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Table of Contents; Preface; Introduction; Part I: Elixir/Solution/Suspension/Syrup; Acetazolamide Suspension 25 mg/mL*; Acetylcysteine Solution 10 mg/mL; Acetylcysteine Solution 100 mg/mL; Allopurinol Suspension 20 mg/mL*; Amiodarone Suspension 5 mg/mL*; Amitriptyline Syrup 1 mg/mL*; Amlodipine Suspension 1 mg/mL*; Amphetamine and Dextroamphetamine (Adderall) Suspension 1 mg/mL*; Aprepitant Suspension 20 mg/mL*; Atenolol Syrup 2 mg/mL-Formulation 1*; Atenolol Syrup 2 mg/mL-Formulation 2*; Azathioprine Suspension 50 mg/mL*; Baclofen Suspension 10 mg/mL; Baclofen Syrup 5 mg/mL* | |
| 505 | 8 | |a Benazepril Hydrochloride Suspension 2 mg/mLBethanechol Solution 1 mg/mL; Bethanechol Suspension 5 mg/mL*; Buspirone Hydrochloride Syrup 2.5 mg/mL*; Busulfan Syrup 2 mg/mL; Candesartan Suspension 1 mg/mL; Captopril Solution 1 mg/mL*; Captopril Suspension 0.75 mg/mL; Captopril Suspension 1 mg/mL*; Carvedilol Suspension 0.1 mg/mL; Carvedilol Suspension 1.67 mg/mL*; Chloroquine Phosphate Suspension 15 mg/mL; Chloroquine Phosphate Syrup 16.7 mg/mL*; Chlorpromazine Hydrochloride Syrup 100 mg/mL; Clonazepam Suspension 0.1 mg/mL*; Clonidine Suspension 0.01 mg/mL; Clonidine Syrup 0.1 mg/mL. | |
| 505 | 8 | |a Clopidogrel Suspension 5 mg/mL*Codeine Phosphate Syrup 3 mg/mL; Cyclophosphamide Elixir 2 mg/mL; Cyclophosphamide Suspension 10 mg/mL*; Dantrolene Syrup 5 mg/mL*; Dapsone Suspension 2 mg/mL*; Dapsone Syrup 2 mg/mL*; Diltiazem Hydrochloride Suspension 12 mg/mL*; Dipyridamole Suspension 10 mg/mL*; Disopyramide Syrup 1 mg/mL; Disopyramide Syrup 10 mg/mL*; Dolasetron Suspension 10 mg/mL*; Ethacrynic Acid Solution 1 mg/mL*; Etoposide Solution 10 mg/mL; Flecainide Acetate Suspension 20 mg/mL*; Flecainide Acetate Syrup 5 mg/mL; Flucytosine Suspension 10 mg/mL*; Flucytosine Suspension 50 mg/mL# | |
| 505 | 8 | |a Hydralazine Suspension 4 mg/mL*Hydrocortisone Suspension 1 mg/mL; Hydrocortisone Suspension 2 mg/mL*; Hydroxyurea Syrup 100 mg/mL*; Hypromellose Suspension 10 mg/mL; Indinavir Liquid 10 mg/mL; Isradipine Syrup 1 mg/mL*; Ketoconazole Suspension 20 mg/mL*; Labetalol Hydrochloride Suspension 40 mg/mL; Labetalol Hydrochloride Syrup 10 mg/mL*; Lamotrigine Suspension 1 mg/mL*; Lansoprazole Solution 3 mg/mL; Lansoprazole Suspension 3 mg/mL; Levothyroxine Solution 25 mcg/mL*; Lisinopril Suspension 1 mg/mL; Lisinopril Syrup 1 mg/mL; Lisinopril Syrup 2 mg/mL*; Losartan Suspension 2.5 mg/mL* | |
| 505 | 8 | |a Melatonin 1 mg/mL and Pyridoxine Hydrochloride 3.3 mg/mL SuspensionMelatonin Suspension 1 mg/mL; Methylcellulose Suspension 10 mg/mL (1%); Methyldopa Syrup 50 mg/mL; Metolazone Suspension 1 mg/mL*; Metoprolol Tartrate Suspension 10 mg/mL*; Metronidazole Suspension 10 mg/mL; Metronidazole Suspension 50 mg/mL*; Metronidazole Syrup 5 mg/mL; Mexiletine Solution 10 mg/mL*; Midazolam Gelatin 1 mg/mL; Midazolam Gelatin 2 mg/mL; Moxifloxacin Suspension 20 mg/mL; Naratriptan Suspension 0.5 mg/mL; Nifedipine Solution 10 mg/mL; Nifedipine Suspension 1 mg/mL; Olmesartan Suspension 2 mg/mL. | |
| 500 | |a Omeprazole Solution 2 mg/mL. | ||
| 588 | 0 | |a Print version record. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drugs |x Dosage forms |v Laboratory manuals. | |
| 650 | 0 | |a Older people. | |
| 650 | 0 | |a Children. | |
| 650 | 0 | |a Suspensions (Chemistry) | |
| 650 | 1 | 2 | |a Drug Compounding |
| 650 | 2 | 2 | |a Aged |
| 650 | 2 | 2 | |a Child |
| 650 | 2 | 2 | |a Formularies as Topic |
| 650 | 2 | 2 | |a Pharmaceutical Solutions |
| 650 | 2 | 2 | |a Suspensions |
| 650 | 6 | |a Médicaments |x Formes pharmaceutiques |v Manuels de laboratoire. | |
| 650 | 6 | |a Personnes âgées. | |
| 650 | 6 | |a Enfants. | |
| 650 | 6 | |a Suspensions (Chimie) | |
| 650 | 7 | |a elderly. |2 aat | |
| 650 | 7 | |a children (people by age group) |2 aat | |
| 650 | 7 | |a Suspensions (Chemistry) |2 fast | |
| 650 | 7 | |a Older people |2 fast | |
| 650 | 7 | |a Children |2 fast | |
| 650 | 7 | |a Drugs |x Dosage forms |2 fast | |
| 655 | 2 | |a Laboratory Manual | |
| 655 | 7 | |a Laboratory manuals |2 fast | |
| 655 | 7 | |a Laboratory manuals. |2 lcgft | |
| 655 | 7 | |a Manuels de laboratoire. |2 rvmgf | |
| 700 | 1 | |a Soo-Hoo, Winson, |e author. | |
| 700 | 1 | |a Erush, Sarah C., |e author. | |
| 700 | 1 | |a Amiri, Elham, |e author. | |
| 758 | |i has work: |a Extemporaneous formulations for pediatric, geriatric, and special needs patients (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGt78KrfkkqTxJrQgJXFBq |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Jew, Rita K. |t Extemporaneous formulations for pediatric, geriatric, and special needs patients. |b Third edition. |d Bethesda, MD : American Society of Health-System Pharmacists, Inc., [2016] |z 9781585285242 |w (DLC) 2015039372 |w (OCoLC)925266381 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4454454 |z Texto completo |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL4454454 | ||
| 938 | |a Teton Data Systems |b STAT |n tds878 | ||
| 938 | |a Teton Data Systems |b STAT |n tds775 | ||
| 938 | |a YBP Library Services |b YANK |n 12898528 | ||
| 994 | |a 92 |b IZTAP | ||